Miracle-dz/UniFAR-FTUs huggingface dataset:
Effect of 50 000 IU vitamin A given with BCG vaccine on mortality in infants in Guinea-Bissau: randomised placebo controlled trial

Objective To investigate the effect of high dose vitamin A supplementation given with BCG vaccine at birth in an African setting with high infant mortality. Design Randomised placebo controlled trial. Setting Bandim Health Project’s demographic surveillance system in Guinea-Bissau, covering approximately 90 000 inhabitants. Participants 4345 infants due to receive BCG. Intervention Infants were randomised to 50 000 IU vitamin A or placebo and followed until age 12 months. Main outcome measure Mortality rate ratios. Results 174 children died during follow-up (mortality=47/1000 person-years). Vitamin A supplementation was not significantly associated with mortality; the mortality rate ratio was 1.07 (95% confidence interval 0.79 to 1.44). The effect was 1.00 (0.65 to 1.56) during the first four months and 1.13 (0.75 to 1.68) from 4 to 12 months of age. The mortality rate ratio in boys was 0.84 (0.55 to 1.27) compared with 1.39 (0.90 to 2.14) in girls (P for interaction=0.10). An explorative analysis revealed a strong interaction between vitamin A and season of administration. Conclusions Vitamin A supplementation given with BCG vaccine at birth had no significant benefit in this African setting. Although little doubt exists that vitamin A supplementation reduces mortality in older children, a global recommendation of supplementation for all newborn infants may not contribute to better survival. Trial registration Clinical trials NCT00168597.
Hybrid analog-digital beam training for mmWave systems with low-resolution RF phase shifters

Millimeter wave (mmWave) wireless technologies are expected to exploit large-scale multiple-input multiple-output and adaptive antenna arrays at both the transmitter and receiver to deal with unfavorable radio propagation and realize sufficient link margin. However, the high cost and power consumption of mmWave radio components prohibit the use of fully-digital precoding/combining architectures, which incurs one dedicated RF chain per antenna element. This paper proposes a practical design of multi-beamwidth codebook exploiting hybrid analog-digital architectures with a number of RF chains much lower than the number of antenna elements and 2-bit RF phase shifters. The proposed solution relies on the orthogonal matching pursuit algorithm enhanced by a dynamic dictionary learning mechanism. Simulation results show that the designed hybrid codebooks are able to shape beam patterns very close to those attained by a fully-digital beamforming architecture. Furthermore, when leveraged in the framework of an adaptive, multiresolution beam training protocol, our hybrid codebooks are able to estimate the most promising angle-of-departure and angle-of-arrival directions with extreme accuracy, yet requiring lower complexity hardware compared to the state of art.
Real‐time causal message ordering in multimedia systems

Messages that are sent to and received by multiple sites need to have a consistent order imposed by all sites. Causal ordering allows the cause and effect relations of messages to be maintained. This paper presents an algorithm that ensures that multimedia data with real‐time deadlines are delivered to the application layer in causal order. The algorithm is designed to ensure that any message that arrives at a destination site before its deadline will be delivered to the application before the message expires. In addition, by focusing on a form of causal ordering violations caused by “the triangle inequality”, this algorithm has a low overhead with respect to the amount of information that must be appended to each message.
Channel-based connectivity management middleware for seamless integration of heterogeneous wireless networks

This paper presents a middleware architecture for the adaptable management of heterogeneous wireless resources. The main application of the proposed architecture is the optimal utilization of multiple wireless access networks, in particular integrated WLAN and 3G environment. The architecture is based on the adaptive maintenance of communication channel during its creation as well as I/O operation. We present our architecture and describe an implementation of a system based on the architecture. Experiments were performed in a GPRS-WLAN integrated environment. Performance metrics were measured and analyzed.
Mobility Management Research of Internet Based on the Splitting Mechanism

This paper proposes a new Internet architecture based on splitting Mechanism. It separates the Internet access networks from the core network, and makes the IPv6 routing both in access networks and the core network more scalable. Furthermore, this paper gives the mobility management protocol of the proposed Internet architecture which supports the host based and the network based mobility management methods. Besides, we develop the analytic models for the mobility management costs and handover latency, and analyze the impacts of mobility and system parameters on mobility management costs and handover latency, respectively. The analytic results show that the handover latency of the proposed mobility management protocol is bigger due to location management messages across more network process nodes and the network based mobility management is better than the host based mobility management in term of the handover latency.
Pregnancy outcome of assisted reproductive technology cycle in patients with hypogonadotropic hypogonadism

CONTEXT: Ovulation induction in patients with hypogonadotropic hypogonadism (HH) is a challenge to the treating physician. The threshold for ovarian response in HH may differ substantially from that of normal patients. To reach that threshold levels of follicle stimulating hormone, in a step-up protocol longer duration of stimulation is required in some cases so as to prevent multiple pregnancy and to eliminate the risk of ovarian hyperstimulation syndrome. AIM: To evaluate the duration of stimulation, quality of oocytes, and embryo, and the pregnancy outcome in the assisted reproductive technology (ART) cycles in patients with HH. MATERIALS AND METHODS: Over the period of 4 years, we had 14 patients with HH in whom 21 cycles of ovulation induction were done. Of these 7 patients underwent oocyte retrieval and intracytoplasmic sperm injection (ICSI). We present a retrospective study of these 7 patients who underwent ART to evaluate the duration of stimulation, quality of oocytes and embryo, and the pregnancy outcome. RESULTS: In the study group on ovulation induction with gonadotropins, only one patient had the duration of stimulation of the standard 12 days, the remaining 6 patients took ≥12 days to respond to stimulation (maxium being 54 days). Mean ET in these patients was 8.9 mm. Six patients had >70% good quality MII oocytes. One patient responded poorly and had only 2 good quality MII oocytes (50%). After ICSI procedure, resultant embryos were of grade 1 and 2 in all the patients irrespective of the duration of stimulation. Fertilization rate in these patients was 85% (except in one 50% fertilization rate), and the cumulative pregnancy rate was 68.6%. CONCLUSION: In the patients with HH the quality of oocytes and embryos, and the pregnancy rate is not affected even if the duration of stimulation is prolonged.
Implementation and performance of application-controlled file caching

Traditional file system implementations do not allow applications to control file caching replacement decisions. We have implemented two-level replacement, a scheme that allows applications to control their own cache replacement, while letting the kernel control the allocation of cache space among processes. We designed an interface to let applications exert control on replacement via a set of directives to the kernel. This is effective and requires low overhead. We demonstrate that for applications that do not perform well under traditional caching policies, the combination of good application-chosen replacement strategies, and our kernel allocation policy LRU-SP, can reduce the number of block I/Os by up to 80%, and can reduce the elapsed time by up to 45%. We also show that LRU-SP is crucial to the performance improvement for multiple concurrent applications: LRU-SP fairly distributes cache blocks and offers protection against foolish applications.
Estrellita

In this article, we describe the design process and principles used in the development of Estrellita, a tool to support parents of preterm infants to track health data. We tested Estrellita in the homes of seven families for 4 months while following seven additional families without Estrellita. The feedback from this trial, including in-depth interviews, surveys, and log analyses, sheds light on how parents can use a mobile data collection tool to enhance their problem-solving processes about their own health and that of their infants, as well as to share with others who support them in this care. In addition to presenting the design of a recording technology for preterm infants and its use in a real-life setting, the results of this research provide a deep understanding of how technology can and should be used to support home care of at-risk patients, in which data capture may be essential.
Watching user generated videos with prefetching

Even though user generated video sharing sites are tremendously popular, the experience of the user watching videos is often unsatisfactory. Delays due to buffering before and during a video playback at a client are quite common. In this paper, we present a prefetching approach for user-generated video sharing sites like YouTube. We motivate the need for prefetching by showing that video playbacks of videos of YouTube is often unsatisfactory and introduce a series of prefetching schemes: the conventional caching scheme, the search result-based prefetching scheme, and the recommendation-aware prefetching scheme. We evaluate and compare the proposed schemes using user browsing pattern data collected from network measurement. We find that the recommendation-aware prefetching approach can achieve an overall hit ratio up to 81%, while the hit ratio achieved by the caching scheme can only reach 40%. Thus, the recommendation-aware prefetching approach demonstrates a strong potential for improving the playback quality at the client. We also explore the trade-offs and feasibility of implementing recommendation-aware prefetching.
Solvent and substrate effects on inkjet-printed dots and lines of silver nanoparticle colloids

The shape changes of inkjet-printed dots and lines were investigated by varying the primary solvent of nanosilver colloids, surface wettability and substrate temperature. The morphological changes in dots and lines in array patterns due to the interaction between neighboring dots or lines during evaporation was also examined for two different nanosilver colloids. In order to examine the effect of solvent evaporation rate, two different solvents with different boiling points (BP) were employed for nanosilver inks. With a fluorocarbon film coating and subsequent ultraviolet ozone (UV/O3) treatment, various surface wettability conditions were obtained on silicon (Si) wafers. Substrate temperature was varied from room temperature to 80 °C, and droplets from a 50 µm diameter nozzle were printed onto the substrate after optimizing the ejection of individual droplets. The results indicate that the shapes and sizes of dots and lines are sensitive to changes in both surface energy and substrate temperature, and the ink with a higher BP solvent produces larger dots under the same surface condition due to its slower evaporation. Dots and lines with better quality are achieved using the ink with a lower BP solvent. The morphological changes in dot and line arrays are dependent on the evaporation rate of the primary solvent as well as the distance between neighboring features. As a result, selecting a proper solvent for nanosilver ink is very crucial for controlling the shape and morphology of inkjet-printed patterns.
Molecular cloning of cDNA for CENP-B, the major human centromere autoantigen

We have isolated a series of overlapping cDNA clones for approximately 95% of the mRNA that encodes CENP-B, the 80-kD human centromere autoantigen recognized by patients with anticentromere antibodies. The cloned sequences encode a polypeptide with an apparent molecular mass appropriate for CENP-B. This polypeptide and CENP-B share three non- overlapping epitopes. The first two are defined by monoclonal antibodies elicited by injection of cloned fusion protein. Epitope 1 corresponds to a major antigenic site recognized by the anticentromere autoantibody used to obtain the original clone. Epitope 2 is a novel one not recognized by the autoantibody. These epitopes were shown to be distinct both by competitive binding experiments and by their presence or absence on different subcloned portions of the fusion protein. The third independent epitope, recognized by a subset of anticentromere- positive patient sera, maps to a region substantially closer to the amino terminus of the fusion protein. DNA and RNA blot analyses indicate that CENP-B is unrelated to CENP-C, a 140-kD centromere antigen also recognized by these antisera. CENP-B is the product of a 2.9-kb mRNA that is encoded by a single genetic locus. This mRNA is far too short to encode a polypeptide the size of CENP-C. The carboxy terminus of CENP-B contains two long domains comprised almost entirely of glutamic and aspartic acid residues. These domains may be responsible for anomalous migration of CENP-B on SDS-polyacrylamide gels, since the true molecular mass of CENP-B is approximately 65 kD, 15 kD less than the apparent molecular mass deduced from gel electrophoresis. Quite unexpectedly, immunofluorescence analysis using antibodies specific for CENP-B reveals that the levels of antigen vary widely between chromosomes.
Use of Selective Serotonin Reuptake Inhibitors and Risks of Stroke in Patients with Obsessive Compulsive Disorder: A Population-Based Study

Background Previous research has suggested a link between antidepressants use and the development of cerebrovascular events, but there has never been any study investigating the risk of stroke in obsessive-compulsive disorder (OCD) patients treated with a selective serotonin reuptake inhibitor (SSRI). Methods A retrospective observational cohort study was conducted using data from the National Health Insurance Database of Taiwan between the year of 2001 and 2009. A total of 527 OCD patients with 412 subjects in the SSRI use group and 115 in the non SSRI use group were included. Multivariable Cox proportional-hazards models were used to explore the associations between SSRI use and the occurrence of stroke, controlling for age, gender, concomitant medications, and comorbid medical illnesses. Results A total of nineteen OCD patients were diagnosed with new onset of stroke during the follow-up period including six cases in the SSRI group and thirteen in the non SSRI use group. SSRI use was demonstrated to be associated with a decreased risk of stroke (hazard ratio [HR] = 0.30; 95% confidence interval [CI] = 0.10–0.86, P = 0.02). The increase in age-related risk of strokes was 2.55 per decade (HR = 2.55; 95% CI = 1.74–3.75, P<0.001). Alternatively, sex, concomitant use of aspirin and non-steroidal anti-inflammatory drugs, and comorbidities with angina pectoris, diabetes mellitus, hypertension, and hyperlipidemia were not found to be associated with an increased risk for stroke in OCD patients. Conclusions Our study showed that SSRI use was associated with decreased risk of stroke in OCD patients. Further investigation into the possible biological mechanisms underlying the relationship between stroke and SSRI use in OCD patients is warranted.
Detection of Borrelia burgdorferi, Ehrlichia chaffeensis, and Anaplasma phagocytophilum in Ticks (Acari: Ixodidae) from a Coastal Region of California

Abstract A study was conducted in Santa Cruz County to estimate the prevalence and distribution of the agents of Lyme disease, human granulocytic (HGE), and human monocytic (HME) ehrlichiosis in 1,187 adult ixodid ticks collected from eight public-use recreation areas over a 2-yr period. Borrelia burgdorferi, the causative agent of Lyme disease, was detected by a polymerase chain reaction (PCR) in 44 of 776 (5.67%) Ixodes pacificus ticks and in 3 of 58 (5.17%) Dermacentor variabilis ticks. Anaplasma phagocytophilum, the causative agent of HGE, was detected by PCR in 48 (6.19%) I. pacificus ticks and 5 (8.62%) D. variabilis ticks. Ehrlichia chaffeensis, the causative agent of HME, was detected by nested PCR in just five (0.64%) I. pacificus ticks and four (6.9%) D. variabilis ticks. Interestingly, eight (1.03%) I. pacificus ticks were co-infected with B. burgdorferi and A. phagocytophilum, and just one (0.12%) tick was co-infected with B. burgdorferi and E. chaffeensis. Less than 1% of 353 Dermacentor occidentalis ticks showed evidence of infection with any of the agents tested. To our knowledge, this is the first reported identification of A. phagocytophilum and E. chaffeensis in D. occidentalis ticks from California. This study represents the first extensive survey of Lyme and the ehrlichial diseases across multiple areas of Santa Cruz County, and suggests that prevalence of B. burgdorferi in Santa Cruz County may be higher than other areas of the state.
Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation

Summary Edoxaban is a novel, orally available, highly specific direct inhibitor of factor Xa and is currently being developed for the treatment and prevention of venous thromboembolism and prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF). The objectives of the present analyses were to characterise edoxaban population pharmacokinetics (PPK) and identify potential intrinsic and extrinsic factors affecting variability in edoxaban exposure, determine if there are relationships between edoxaban pharmacokinetics or biomarkers and the risk of bleeding in patients with NVAF using an exposure-response model, and to use the PPK and exposure-response model to support dose selection for a phase III trial of edoxaban in patients with NVAF. PPK analysis of data from 1,281 edoxaban-dosed subjects with intrinsic factors such as renal impairment or NVAF and extrinsic factors such as concomitant medications revealed significant effects of renal impairment and concomitant strong P-glycoprotein (P-gp) inhibitors on the pharmacokinetics of edoxaban. Exposure-response analysis found that in patients with NVAF, the incidence of bleeding events increased significantly with increasing edoxaban exposure, with steady-state minimum concentration (Cmin,ss) showing the strongest association. Clinical trial simulations of bleeding incidence were used to select 30 mg and 60 mg once-daily edoxaban with 50% dose reductions for patients with moderate renal impairment or receiving concomitant strong P-gp inhibitors as the treatment regimens in the ENGAGE AF-TIMI 48 (NCT00781391) trial. The results of this study were previously presented at the 2009 International Society on Thrombosis and Haemostasis, July 2009, Boston, Massachusetts, USA.
Nitric Oxide Does Not Significantly Contribute to Changes in Pulse Pressure Amplification During Light Aerobic Exercise

NO modulates resting blood pressure and wave reflection. The effect of NO on exercise central hemodynamics is unknown but has important implications relating to cardiovascular risk. The aim of this study was to determine the contribution of NO to pulse pressure (PP) amplification and wave reflection during exercise. Twelve healthy men aged 29±1 years (mean±SEM) undertook cycle exercise at 60% of their maximal heart rate. Noninvasive measures of central blood pressure, estimated aortic pulse wave velocity, and wave reflection (augmentation index) were obtained by pulse wave analysis during intravenous infusion of saline (control), NG-monomethyl-l-arginine (a NO-synthase inhibitor), or noradrenaline (control vasoconstrictor). PP amplification was defined as the ratio of peripheral to central PP. Cardiac output and stroke volume were determined by electric bioimpedance. Both NG-monomethyl-l-arginine and noradrenaline caused a significant increase in mean arterial pressure (P<0.01) and augmentation index (P<0.01), as well as reduced ratio of peripheral to central PP (P<0.05) at baseline. Exercise caused a significant increase in the ratio of peripheral to central PP (P<0.001), whereas augmentation index and estimated aortic pulse wave velocity declined (for both P<0.05) during all 3 of the infusion protocols. However, no significant differences were observed in augmentation index, ratio of peripheral to central PP, or estimated aortic pulse wave velocity between infusion procedures (P>0.50) during exercise. Also, heart rate, peripheral vascular resistance, and cardiac output did not differ during exercise between saline, NG-monomethyl-l-arginine, or noradrenaline. Although we cannot rule out other vasodilator mechanisms having adjusted for NO blockade, our results indicate that NO does not solely contribute to systemic arterial stiffness or altered blood pressure amplification during light exercise.
Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis

Several treatments are currently available for relapsing-remitting multiple sclerosis. Among them, interferon (IFN) beta remains a valid treatment approach because of its good benefit/risk profile. Due to the need for frequent administration (weekly, at a minimum), the use of IFN beta is limited by uncomfortable side effects that could reduce adherence to and persistence with the treatment. The use of subcutaneous polyethylene glycol (PEG)ylated interferon beta-1a (PEG-IFN) has been proposed to offer a better combination of pharmacokinetic and pharmacodynamic profiles and therapy-related side effects. A 125 μg dose of PEG-IFN given every 2 or 4 weeks was tested in two Phase I studies and shown to be as safe and efficient as IFN beta-1a but with a longer half-life. A Phase III trial (ADVANCE) comparing 125 μg of PEG-IFN given every 2 or 4 weeks with placebo in 1,512 patients with relapsing-remitting multiple sclerosis showed significant reductions in both the annualized relapse rate (ARR) and the occurrence of new or newly enlarged T2 brain lesions in both experimental groups versus placebo after the first year. Moreover, 38% fewer patients showed progression of disability (P=0.04) in the PEG-IFN groups. During the second year, the ARR was further reduced in the PEG-IFN 2-week treatment group (0.230 at 1 year versus 0.178 at 2 years) and was maintained in the 4-week treatment group. Patients who received immediate PEG-IFN treatment showed improved clinical efficacy (ARR, risk of relapse, 12-week disability progression) and magnetic resonance imaging parameters (new T2 and newly enlarging lesions, gadolinium-positive lesions) compared with those with delayed treatment. The effects were more evident with the 2-week dose for all endpoints considered. Furthermore, PEG-IFN was well tolerated, and no new safety concerns arose. In conclusion, PEG-IFN has good efficacy and a good safety profile. The available data support the use of PEG-IFN as a suitable therapeutic option in patients with relapsing-remitting multiple sclerosis.